Medtronic (MDT) had its "hold" rating reaffirmed by Jefferies Financial Group Inc..
Medtronic (MDT) was downgraded by
Weiss Ratings from "buy (b-)" to "hold (c+)".
Medtronic (MDT) had its price target lowered by UBS Group AG from $104.00 to $90.00. They now have a "neutral" rating on the stock.
Medtronic completes acquisition of CathWorks, expanding its leadership in transforming care for patients with cardiovascular disease [TheStreet.com]
Medtronic completes acquisition of CathWorks, expanding its leadership in transforming care for patients with cardiovascular disease [Yahoo! Finance]